Medicare negotiation

Politics Rachel Cohrs

STAT Plus: Drugmakers will be penalized if they hike prices on patients in private insurance market

Exclusive Rachel Cohrs

STAT Plus: Medicare tasks a senior adviser with staffing its new drug pricing division

Exclusive Rachel Cohrs

STAT Plus: Medicare lays out the bureaucracy it will need to negotiate drug prices

Matt's Take Matthew Herper

STAT Plus: The Senate’s drug pricing bill is an inevitable solution. It will still have plenty of unintended consequences

D.C. Diagnosis Rachel Cohrs

The view on drug pricing from Wall Street, a pharma-friendly Dem holds firm, and what’s next for a big telehealth bill

Politics Rachel Cohrs

STAT Plus: ‘What can we do?’: Pharma lobbyists face their biggest test in a decade, as Democrats barrel toward a vote on drug pricing

Politics Nicholas Florko

STAT Plus: Powerful Senate Democrat outlines ‘plenty’ more drug pricing reforms to follow Medicare negotiation

Politics Alan Fram — Associated Press

STAT Plus: Biden tells Dems to quickly pass pared-down economic package

Politics Rachel Cohrs

STAT Plus: Democrats tweak their drug pricing plan in last-ditch effort to pass reforms

Politics Nicholas Florko

STAT Plus: Three years after the Senate grilled drugmakers … nothing’s changed

Politics Rachel Cohrs

STAT Plus: Insulin giants Eli Lilly and Novo Nordisk boosted their lobbying spending as Democrats eyed pricing reform

D.C. Diagnosis Nicholas Florko

What does the Build Back Better Act actually mean for the health care industry?

Exclusive Rachel Cohrs

How Nancy Pelosi almost killed drug pricing reform — a gamble that expanded Democrats’ final deal

Politics Rachel Cohrs

STAT Plus: Here’s who wins and loses in Democrats’ new prescription drug pricing deal

Politics Lev Facher and Rachel Cohrs

STAT Plus: Democrats circulate a new drug pricing outline with a big carveout for small biotechs

Politics Nicholas Florko and Rachel Cohrs

STAT Plus: Here’s where Democrats’ resurrected drug pricing talks are headed

Politics Lev Facher

STAT Plus: Here’s how Biden can address high drug prices, without help from Congress

Politics Rachel Cohrs

STAT Plus: Pelosi working to gather support for last-minute, last-ditch drug pricing policy

Politics Rachel Cohrs

STAT Plus: Biden abandons his push to lower drug prices

Politics Rachel Cohrs

STAT Plus: The four senators who could make or break Democrats’ drug pricing ambitions

Politics Nicholas Florko

STAT Plus: Underpinning Sinema’s outspoken opposition to major drug pricing reforms: her close ties to Arizona biotechs

Exclusive Rachel Cohrs and Nicholas Florko

STAT Plus: Key Senate committee considers a carveout for small biotech companies in drug pricing reforms

Politics Rachel Cohrs and Nicholas Florko

STAT Plus: In May, 10 moderate Democrats opposed major drug pricing reform. Ahead of a key vote, that list is shrinking

Politics Rachel Cohrs

STAT Plus: Democrats want to let Medicare negotiate drug prices. Has pharma found a way to lessen the blow, already?